| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Mibi04g1686 | ATGGCTCAACGTTCTCAAGTACCGAGATTTGGCAGTTGGGAAAATGAAGATAATGTTCCTTATACAGCTTATTTTGAGCAGGCACGAAAAGATCGAACTGGCTCAAGGATGAATCCAAATGCTCCTGAGGGAAATCCTGATTTAGTTCATGTTGATTCATCTTCTTCCAATGTCCCACCTACTGAACACATGGGTAAATCAGAGGACCAAACTGGAAAAGGATCAGTGAGACCATCAATTGAATTACAGAAGAGCAAGGATGATGCTGTTCCTAAGCCTTCTACTGACTCTCCAGCTCGTCATGACAACATGGGCAATAGAAGTGGAAATGATTCTACACATCGACAAGGAGTAGGTTCTGCTGACACTCGTCAAAAACCTGCAAAACAAAATGCTGGGTCTGAGTATAGTATTGAACGCTCACCACTTCATCGCCTGGTAAAGACCCCAGGCAGAGATAGTCCCTCTTGGGAAGGAGGAAAGAATTCCTATGACAGCAGCCACGGTACGCCGGGAAGATCTCGACTAAGAACACCTAATCGAGGAGATGAATCCCCTGACAAAGCTGCTTCTGTTCCCAAATTTGGTGATTGGGATGAAAATGACCCTACATCGGCTGATGGCTACACTCAACTCTTCAACAAAGTGAAGGAGGAGAAAGCTGGTGCTGGACAAGCTACTGGCACGCCCACCCAGAGACCATATGTTGTCAGGAACTCAAACGCTAGTGACAAAGCAAAGGGTTGCTGCTTTGGCTGAGCAACTTTACGGTTAGCAATGGCGTGGAGAGGAAATCTTTCAAAGTACCTGAAGGAGGTTAGGTTTCTGATGTGCCAGACATCGCCTGCTAGCTCAACCACAAGGTCATTTGTGGAGAAGAATTATAAGGAGCTAAAGACATTGAACCCCAAATTGCCAATTTTGATCCGTGAATGCAGTGGGGTCGAACCCCAATTGTGGGCAAGATATGACTTGGGTGTTGAGAAAGGCATCAGATTGGATGGTTTGACAGAAGAGCAGATTTCTAAGGCACTTCAAGATCTGGTAAAAGCTGGAGAGTCTCTTAAAGCTTGA | 1074 | 0.4553 | MAQRSQVPRFGSWENEDNVPYTAYFEQARKDRTGSRMNPNAPEGNPDLVHVDSSSSNVPPTEHMGKSEDQTGKGSVRPSIELQKSKDDAVPKPSTDSPARHDNMGNRSGNDSTHRQGVGSADTRQKPAKQNAGSEYSIERSPLHRLVKTPGRDSPSWEGGKNSYDSSHGTPGRSRLRTPNRGDESPDKAASVPKFGDWDENDPTSADGYTQLFNKVKEEKAGAGQATGTPTQRPYVVRNSNASDKAKGCCFGXATLRLAMAWRGNLSKYLKEVRFLMCQTSPASSTTRSFVEKNYKELKTLNPKLPILIRECSGVEPQLWARYDLGVEKGIRLDGLTEEQISKALQDLVKAGESLKA | 357 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Mibi04g1686 | 357 | Pfam | Cleavage site for pathogenic type III effector avirulence factor Avr | 186 | 221 | IPR008700 | - | |
| Mibi04g1686 | 357 | MobiDBLite | consensus disorder prediction | 159 | 174 | - | - | |
| Mibi04g1686 | 357 | MobiDBLite | consensus disorder prediction | 99 | 137 | - | - | |
| Mibi04g1686 | 357 | SUPERFAMILY | Thioredoxin-like | 270 | 351 | IPR036249 | - | |
| Mibi04g1686 | 357 | PANTHER | NADH-UBIQUINONE OXIDOREDUCTASE B8 SUBUNIT | 260 | 354 | IPR016464 | - | |
| Mibi04g1686 | 357 | Pfam | Mitochondrial ribosomal protein L51 / S25 / CI-B8 domain | 287 | 337 | IPR007741 | - | |
| Mibi04g1686 | 357 | MobiDBLite | consensus disorder prediction | 80 | 95 | - | - | |
| Mibi04g1686 | 357 | MobiDBLite | consensus disorder prediction | 1 | 236 | - | - | |
| Mibi04g1686 | 357 | Gene3D | Glutaredoxin | 258 | 351 | - | - | |
| Mibi04g1686 | 357 | FunFam | NADH-ubiquinone oxidoreductase 10.5 kDa subunit | 261 | 351 | - | - | |
| Mibi04g1686 | 357 | MobiDBLite | consensus disorder prediction | 49 | 64 | - | - | |
| Mibi04g1686 | 357 | MobiDBLite | consensus disorder prediction | 177 | 195 | - | - | |
| Mibi04g1686 | 357 | SMART | L51_S25_CI_B8_2 | 279 | 352 | IPR007741 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Mibi04g1686 | Mibi-ChrMibi04 | 45121985 | 45128673 | Dispersed/Wgd |
| Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
|---|---|---|---|---|---|---|---|---|---|
| Mibi11g0502 | 11 | 9652823 | 9659472 | Mibi04g1686 | 04 | 45121985 | 45128673 | CCT |